Nat Med

• 

  Publication Venue For

  • T cell-inducing vaccine durably prevents mucosal SHIV infection even with lower neutralizing antibody titers..  26:932-940. 2020
  • A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia..  26:760-768. 2020
  • Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017..  26:750-759. 2020
  • SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes..  26:681-687. 2020
  • Viable bacterial colonization is highly limited in the human intestine in utero..  26:599-607. 2020
  • A case report of clonal EBV-like memory CD4+ T cell activation in fatal checkpoint inhibitor-induced encephalitis..  25:1243-1250. 2019
  • Causal associations of blood lipids with risk of ischemic stroke and intracerebral hemorrhage in Chinese adults..  25:569-574. 2019
  • Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer..  25:628-640. 2019
  • Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors..  25:529. 2019
  • Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy..  25:427-432. 2019
  • Author Correction: A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite..  25:188-189. 2019
  • Safety and antiviral activity of combination HIV-1 broadly neutralizing antibodies in viremic individuals..  24:1701-1707. 2018
  • Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells..  24:1536-1544. 2018
  • Route of immunization defines multiple mechanisms of vaccine-mediated protection against SIV..  24:1590-1598. 2018
  • Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors..  24:1459-1468. 2018
  • Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1..  24:857-867. 2018
  • HIV vaccine candidate activation of hypoxia and the inflammasome in CD14+ monocytes is associated with a decreased risk of SIVmac251 acquisition..  24:847-856. 2018
  • A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite..  24:408-416. 2018
  • AI for medical imaging goes deep..  24:539-540. 2018
  • Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis..  24:617-627. 2018
  • Diverse genetic-driven immune landscapes dictate tumor progression through distinct mechanisms..  24:165-175. 2018
  • Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models..  24:194-202. 2018
  • Opposing effects of cancer-type-specific SPOP mutants on BET protein degradation and sensitivity to BET inhibitors..  23:1046-1054. 2017
  • Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4..  23:1063-1071. 2017
  • HDAC3 sets the timer on muscle fuel switching..  23:148-150. 2017
  • Targeting the histone methyltransferase G9a activates imprinted genes and improves survival of a mouse model of Prader-Willi syndrome..  23:213-222. 2017
  • Dickkopf-1 promotes hematopoietic regeneration via direct and niche-mediated mechanisms..  23:91-99. 2017
  • Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling..  22:1475-1481. 2016
  • Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain..  22:1465-1469. 2016
  • Corrigendum: Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition..  22:1192. 2016
  • Adjuvant-dependent innate and adaptive immune signatures of risk of SIVmac251 acquisition..  22:762-770. 2016
  • An oncogenic Ezh2 mutation induces tumors through global redistribution of histone 3 lysine 27 trimethylation..  22:632-640. 2016
  • PPAR-δ is repressed in Huntington's disease, is required for normal neuronal function and can be targeted therapeutically..  22:37-45. 2016
  • TCF1 links GIPR signaling to the control of beta cell function and survival..  22:84-90. 2016
  • Inhibition of mechanical allodynia in neuropathic pain by TLR5-mediated A-fiber blockade..  21:1326-1331. 2015
  • Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases..  21:1018-1027. 2015
  • Breaking bad blood: β2-microglobulin as a pro-aging factor in blood..  21:844-845. 2015
  • Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes..  21:449-456. 2015
  • A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents..  21:27-36. 2015
  • A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer..  20:1340-1347. 2014
  • Reply: the BIM deletion polymorphism cannot account for intrinsic TKI resistance of Chinese individuals with chronic myeloid leukemia..  20:1090-1091. 2014
  • Cardiac BIN1 folds T-tubule membrane, controlling ion flux and limiting arrhythmia..  20:624-632. 2014
  • Lessons from babies: inducing HIV-1 broadly neutralizing antibodies..  20:583-585. 2014
  • Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis..  20:664-669. 2014
  • Straight talk with...Victor Dzau. Interview by Roxanne Khamsi..  20:325. 2014
  • Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progression..  20:360-367. 2014
  • Dopamine mediates vagal modulation of the immune system by electroacupuncture..  20:291-295. 2014
  • B lymphocytes trigger monocyte mobilization and impair heart function after acute myocardial infarction..  19:1273-1280. 2013
  • Toward better representations of sound with cochlear implants..  19:1245-1248. 2013
  • Regulation of hepatic innate immunity by hepatitis C virus..  19:879-888. 2013
  • Epidermal growth factor regulates hematopoietic regeneration after radiation injury..  19:295-304. 2013
  • Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy..  18:1835-1840. 2012
  • Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines..  18:1673-1681. 2012
  • Gene therapy rescues cilia defects and restores olfactory function in a mammalian ciliopathy model..  18:1423-1428. 2012
  • Neighborhood watch orchestrates liver regeneration..  18:497-499. 2012
  • Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity..  18:595-599. 2012
  • A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer..  18:521-528. 2012
  • Under pressure: the search for the essential mechanisms of hypertension..  17:1402-1409. 2011
  • Somatic deletions of genes regulating MSH2 protein stability cause DNA mismatch repair deficiency and drug resistance in human leukemia cells..  17:1298-1303. 2011
  • Host S-nitrosylation inhibits clostridial small molecule-activated glucosylating toxins..  17:1136-1141. 2011
  • Lung stem cells: looking beyond the hype..  17:788-789. 2011
  • Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy..  17:860-866. 2011
  • Suppression of inflammatory and neuropathic pain by uncoupling CRMP-2 from the presynaptic Ca²⁺ channel complex..  17:822-829. 2011
  • Iduna protects the brain from glutamate excitotoxicity and stroke by interfering with poly(ADP-ribose) polymer-induced cell death..  17:692-699. 2011
  • B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies..  17:610-617. 2011
  • Inhibitors of leucine-rich repeat kinase-2 protect against models of Parkinson's disease..  16:998-1000. 2010
  • Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions..  16:592-597. 2010
  • Getting biological about the genetics of diabetes..  16:388-391. 2010
  • Pleiotrophin regulates the expansion and regeneration of hematopoietic stem cells..  16:475-482. 2010
  • Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys..  16:324-328. 2010
  • Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor..  16:205-213. 2010
  • Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, invasion, metastasis and castration resistance.  16:1414-1420. 2010
  • Modulating hedgehog signaling can attenuate the severity of osteoarthritis..  15:1421-1425. 2009
  • Salmonella disrupts lymph node architecture by TLR4-mediated suppression of homeostatic chemokines..  15:1259-1265. 2009
  • CCL3L1 and HIV/AIDS susceptibility..  15:1110-1112. 2009
  • Development of universal antidotes to control aptamer activity..  15:1224-1228. 2009
  • Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates..  15:746-749. 2009
  • The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases..  15:177-184. 2009
  • Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis..  14:1343-1350. 2008
  • SNO-hemoglobin and hypoxic vasodilation..  14:1008-1009. 2008
  • Mast cell activators: a new class of highly effective vaccine adjuvants..  14:536-541. 2008
  • Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain..  14:331-336. 2008
  • Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation..  14:306-314. 2008
  • Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone..  14:181-187. 2008
  • Oxidative damage-induced inflammation initiates age-related macular degeneration..  14:194-198. 2008
  • Retraction: Genomic signatures to guide the use of chemotherapeutics..  17:135. 2011